Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -18477.83% is 193% below its 5-year average of -6300.90%, near the high end of its 5-year range (-67856.58%–0.00%).
14.47% above its 12-month average of -21604.64%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -32248.67%.
OPERATING MARGIN
-18477.83%
OPERATING MARGIN AVG TTM
-21604.64%
OPERATING MARGIN AVG 3Y
-10501.50%
OPERATING MARGIN AVG 5Y
-6300.90%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+14.47%
CURRENT VS 3Y AVG
-75.95%
CURRENT VS 5Y AVG
-193.26%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 845 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
ProKidney Corp.
Market Cap
$536.32M
Operating Margin
-18477.83%
TTM Avg
-21604.64%
3Y Avg
-10501.50%
5Y Avg
-6300.90%
Market Cap
$535.61M
Operating Margin
-975.91%
TTM Avg
-867.04%
3Y Avg
-586.91%
5Y Avg
-743.36%
Market Cap
$535.43M
Operating Margin
-1.90%
TTM Avg
-16.29%
3Y Avg
-781.66%
5Y Avg
-851.82%
Market Cap
$536.98M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$540.91M
Operating Margin
-5150.80%
TTM Avg
-3279.53%
3Y Avg
-6989.17%
5Y Avg
-4746.54%
Market Cap
$535.09M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$530.71M
Operating Margin
-91.36%
TTM Avg
-296.77%
3Y Avg
-6281.52%
5Y Avg
-4187.68%
Market Cap
$534.45M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$520.08M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ProKidney Corp. (PROK) | $536.32M | -18477.83% | -21604.64% | -10501.50% | -6300.90% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $535.61M | -975.91% | -867.04% | -586.91% | -743.36% |
| Delcath Systems, Inc. (DCTH)vs › | $535.43M | -1.90% | -16.29% | -781.66% | -851.82% |
| Nuvectis Pharma, Inc. (NVCT)vs › | $536.98M | 0.00% | 0.00% | 0.00% | 0.00% |
| Shattuck Labs, Inc. (STTK)vs › | $540.91M | -5150.80% | -3279.53% | -6989.17% | -4746.54% |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $535.09M | 0.00% | 0.00% | 0.00% | 0.00% |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $530.71M | -91.36% | -296.77% | -6281.52% | -4187.68% |
| Monopar Therapeutics Inc. (MNPR)vs › | $534.45M | 0.00% | 0.00% | 0.00% | 0.00% |
| Immix Biopharma, Inc. (IMMX)vs › | $520.08M | 0.00% | 0.00% | 0.00% | 0.00% |
| Altimmune, Inc. (ALT)vs › | $517.30M | -230460.98% | -373160.49% | -159952.53% | -107112.87% |
Gross Margin
100.0%
Operating Margin
-18477.8%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -32248.67% |
| 2026-03-31 | -19881.86% |
| 2025-12-31 | -20164.89% |
| 2025-09-30 | -17759.91% |
| 2025-06-30 | -17967.87% |
| 2025-03-31 | -17994.78% |
| 2024-12-31 | -67856.58% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
